Cytokines - Killers in the brain?

Journal of Physiology

Volumn 514, Issue 1, 1999, Pages 3-17

  Rothwell, Nancy J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; CHEMOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

BRAIN; ENCEPHALITIS; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW; ALZHEIMER DISEASE; ARTICLE; BRAIN DAMAGE; BRAIN DISEASE; BRAIN ISCHEMIA; CACHEXIA; CENTRAL NERVOUS SYSTEM DISEASE; ENERGY BALANCE; HEALTH CARE ORGANIZATION; HUMAN; IMMUNOREGULATION; MOLECULAR MECHANICS; NEUROIMMUNOLOGY; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; THERMOGENESIS; WORKSHOP; ANIMAL; BRAIN LEVEL; IMMUNOLOGY; IMMUNOMODULATION;

ANIMALS; BRAIN CHEMISTRY; BRAIN DISEASES; CYTOKINES; HUMANS; NEUROIMMUNOMODULATION;

EID: 0032950857     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.1999.003af.x     Document Type: Review

References (124)

1. BARINAGA, M. (1998). Stroke-damaged neurons may commit cellular suicide. Science 281, 1302-1303.
2. BAZAN, J., TIMANS, J. C. & KASTLELEIN, R. A. (1996). A newly defined interleukin-1? Nature 379, 591.
3. BENEVISTE, E. N. (1992). Cytokines: influence on glial cell gene expression and function. Neuroimmunoendocrinology 52, 106-153.
4. BETZ, K., SCHIELKE, G. P. & YANG, G.-Y. (1996). Interleukin-1 in cerebral ischaemia. Keio Journal of Medicine 45, 230-238.
5. BETZ, A. L., YANG, G.-Y. & DAVIDSON, B. L. (1995). Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. Journal of Cerebral Blood Flow and Metabolism 15, 547-551.
6. BEUTLER, B. & CERAMI, A. (1989). The biology of cachectin/TNF-α: a primary mediator of the host response. Annual Review of Immunology 7, 625-655.
7. BHAT, R. V., DIROCCO, R., MARCY, V. R., FLOOD, D. G., ZHU, Y., DOBRZANSKI, P., SIMAN, R., SCOTT, R., CONTRERAS, P. C. & MILLER, M. (1996). Increased expression of IL-1beta converting enzyme in hippocampus after ischemia: selective localization in microglia. Journal of Neuroscience 16, 4146-4154.
8. BOMSZTYK, K., SIMS, J. K., STANTON, T. H., SLACK, J., MCMAHAN, C. J., VALENTINE, M. A. & DOWER, S. K. (1989). Evidence for different interleukin-1 receptors in murine B-and T-cell lines. Proceedings of the National Academy of Sciences of the USA 86, 8034-8038.
9. BOXER, P. A. & BIGGE, C. F. (1997). Mechanisms of neuronal cell injury/death and targets for drug intervention. Drug Discovery Today 2, 219-228.
10. BUTTINI, M., SAUTER, A. & BODDEKE, H. W. G. M. (1994). Induction of interleukin-1 beta messenger RXA after focal cerebral ischaemia in the rat. Molecular Brain Research 23, 126-134.
11. CERRETTI, D. P., KOZLOSKY, C. J., MOSLEY, B., NELSON, N., VAN NESS, K. V., GREENSTREET, T. A., MARCH, C. J., KRONHEIM, S. R., DRUCK, T., CANNIZZARO, L. A., HUEBNER, K. & BLACK, R. A. (1992). Molecular cloning of the interleukin-1β converting enzyme. Science 256, 97-102.
12. CHALMERS-REDMAN, R. M. E., FRASER, A. D., Ju, W. Y. H., WADIA, J., TATTON, N. A. & TATTON, W. G. (1997). Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischaemia. In Neuroprotective Agents and Cerebral Ischaemia, ed. GREEN, A. R. & CROSS, A. J., pp. 1-25. Academic Press, New York.
13. CHAO, C. C., HU, S., EHRLICH, L. & PETERSON, P. K. (1995). Interleukin-1 and tumour necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behaviour and Immunology 9, 355-365.
14. CHAO, C. C., HU, S., SHENG, W. S., BU, D., BUKRINSKY, M. I. & PETERSON, P. K. (1996). Cytokine-stimulated astrocytes damage human neurones via a nitric oxide mechanism. Glia 16, 276-284.
15. CHAO, C. C., MOLITOR, T. W. & HU, S. (1993). Neuroprotective role of IL-4 against activated microglia. Journal of Immunology 151, 1473-1481.
16. CHENG, Y., DESHMUKH, M., D'COSTA, A., DEMARO, J. A., GIDDAY, J. M., SHAH, A., SUN, Y., JACQUIN, M. K., JOHNSON, E. M. & HOLTZMAN, D. M. (1998). Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxicischemic brain injury. Journal of Clinical Investigation 101, 1992-1999.
17. COLOTTA, F., RE, F., MUZIO, M., BERTINI, B., POLENTARUTTI, N., SIRONI, M., GIRI, J. G., DOWER, S. K., SIMS, J. E. & MANTOVANI, A. (1993). Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261, 472-475.
18. COOGAN, A. & O'CONNOR, J. J. (1997). Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyms in vitro by IL-1β. NeuroReport 8, 2107-2110.
19. CULHANE, A. C., HALL, M D., ROTHWELL, N. J. & LUHESHI, G. N. (1998). Cloning of rat brain interleukin-18 cDNA. Molecular Psychiatry 3, 362-366.
20. CUNNINGHAM, E., WADA, K., CARTER, D., TRACEY, D., BATTEY, J. & DE SOUZA, E. (1992). In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. Journal of Neuroscience 12, 1101-1114.
21. DAVIES, C. A., LODDICK, S. A., TOULMOND, S., STROEMER, R. P., HUNT, J. & ROTHWELL, N. J. (1998). The progression and topographic distribution of interleukine-1β expression after permanent middle cerebral artery occlusion in the rat. Journal of Cerebral Blood Flow and Metabolism (in the Press).
22. DINARELLO, C. A. (1991). Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652.
23. DINARELLO, C. A. (1996). Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
24. DINARELLO, C. A. (1998). Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. International Review of Immunology 16, 457-499.
25. DINARELLO, C. A., NOVICK, D., PUREN, A. J., FANTUZZI, G., SHAPIRO, L., MUHL, H., YOON, D.-Y., REZNIKOV, L. L., KIM, S.-H. & RUBINSTEIN, M. (1998). Overview of interleukin-18: more than an interferon-γ inducing factor. Journal of Leukocyte Biology 63, 658-664.
26. DINARELLO, C. A. & THOMPSON, R. C. (1991). Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunology Today 12, 404-410.
27. DOBLE, A. (1995). Excitatory amino acid receptors and neurodegeneration. Therapie 50, 319-337.
28. ENDRES, M., NAMURA, S., SHIMIZU-SASAMATA, M., WAEBER, C., ZHANO, L., GOMEZ-ISLA, T., HYMAN, B. T. & MOSKOWITZ, M. A. (1998). Attenuation of delayed neuronal death after mild focal ischaemia in mice by inhibition of the caspase family. Journal of Cerebral Blood Flow and Metabolism 18, 238-247.
29. ERICSSON, A., LIU, C., HART, R. P. & SAWCHENKO, P. E. (1995). Type 1 interleukin1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. Journal of Comparative Neurology 261, 681-698.
30. FRIEDLANDER, R. M., GAGLIARDINI, V., HARA, H., FINK, K. B., LI, W., MACDONALD, G., FISHMAN, M. C., GREENBERRY, A. H., MOSKOWITZ, M. A. & YAN, Y. (1997). Expression of a dominant negative mutant of interleukin-1β converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischaemic brain injury. Journal of Experimental Medicine 185, 933-940.
31. FRIEDLANDER, R. M., GAGLIARDINI, V., ROTELLO, R. J. & YUAN, J. (1996). Functional role of interleukin-1β (IL-1) in IL-1β converting enzyme mediated apoptosis. Journal of Experimental Medicine 184, 717-724.
32. GARCIA, J. H., LIU, K.-F. & RELTON, J. K. (1995). Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. American Journal of Pathology 147, 1477-1486.
33. GARRATTINI, S., BIZZ, A., DONELLI, M. G., GUAITANI, A., SAMANIN, R. & SPREAFICO, F. (1980). Anorexia and cancer in animals and man. Cancer Treatment Reviews 7, 115-139.
34. GIULIAN, D., VACA, K. & CORPUZ, M. (1993). Brain glia release factors with opposing actions upon neuronal survival. Journal of Neuroscience 13, 29-37.
35. GREENFEDER, S. A., NUNES, P., KWEE, L., LABOW, M., CHIZZONITE, R. A. & JU, G. (1995). Molecular cloning and characterisation of a second subunit of the interleukin-1 receptor complex. Journal of Biological Chemistry 270, 13757-13765.
36. GU, Y., KUIDA, K., TSUTSUI, H., KU, G., HSIAO, K., FLEMING, M. A., HAYASHI, N., HIGASHINO, K., OKAMUKA, H., NAKANISKI, K., KURIMOTO, M., TANIMOTO, T., FLAVELL, R. A., SATO, V., HARDING, M. W., LIVINGSTONE, D. J. & SU, M. S. S. (1997). Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275, 206-209.
37. GUTIERREZ, E. G., BANKS, W. A. & KASTIN, A. J. (1994). Blood-borne interleukin-1 receptor antagonist crosses the blood brain barrier. Journal of Neuroimmunology 55, 153-160.
38. HARA, H., FRIEDLANDER, R. M., GAGLIARDINI, V., AYATA, C., FINK, K., HUANG, Z., SHIMIZU-SASAMATA, M., YUAN, J. & MOSKOWITZ, M. A. (1997). Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proceedings of the National Academy of Sciences of the USA 94, 2007-2012.
39. HARTUNG, H.-P., SCHAFER, B., HEININGER, K. & TOYKA, K. V. (1989). Recombinant interleukin-1β stimulates eieosanoid production in rat primary culture astrocytes. Brain Research 489, 113-118.
40. HENKART, P. A. (1996). ICE family proteases: mediators of apoptotic cell death? Immunity 4, 195-201.
41. HOLTZMAN, D. M. & DESHMUKH, M. (1997). Caspases: A treatment target for neurodegenerative diseases? Nature Medicine 3, 954-955.
42. HOPKINS, S. J. & ROTHWELL, N. J. (1995). Cytokines in the nervous system I: Expression and recognition. Trends in Neurosciences 18, 83-88.
43. HU, S., SHENG, W. S., PETERSON, P. K. & CHAO, C. C. (1995). Cytokine modulation of murine microglial cell superoxide production. Glia 13, 45-50.
44. HUANG, J., GAO, X., LI, S. & CAO, Z. (1997). Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proceedings of the National Academy of Sciences of the USA 94, 12829-12832.
45. IANOTTI, K., KIDA, S., WELLER, R., BUHAGIER, G. & HILLHOUSE, E. (1993). Interleukin-1β in focal cerebral ischaemia in rats. Journal of Cerebral Blood Flow and Metabolism 13, s125.
46. LAWRENCE, C. B. (1996). Involvement of interleukin-1 (IL-1) in excitotoxic brain damage. PhD Thesis, Manchester University.
47. LAWRENCE, C. B., ALLAN, S. M. & ROTHWELL, N. J. (1998). Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. European Journal of Neuroscience 10, 1188-1195.
48. LEE, S. C., DICKSON, D. C., LIU, W. & BROSNAN, C. F. (1993). Induction of nitric oxide synthase activity in human astrocytes by interleukin-1α and interferon-γ. Journal of Neuroimmunology 46, 19-23.
49. LIN, M. T., KAO, T. Y., JIN, Y. T. & CHEN, C. F. (1995). Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Research 37, 595-598.
50. LINNICK, M. D. (1995). Programmed cell death in cerebral ischaemia. CNS Drugs 3, 239-244.
51. LIU, T., MCDONNELL, P. C., YOUNG, P. R., WHITE, R. F., SIREN, A. L., HALLENBECK, J. M., BARONE, F. C. & FEUERSTEIN, G. Z. (1993). Interleukin-1 beta mRNA expression in ischaemic rat cortex. Stroke 24, 1746-1751.
52. LODDICK, S. A., LIU, C., TAKAO, T., HASHIMOTO, K. & DE SOUZA, E. B. (1998). Interleukin-1 receptors: cloning studies and role in central nervous system disorders. Brain Research Reviews 26, 306-319.
53. LODDICK, S. A., MACKENZIE, A. & ROTHWELL, N. J. (1996). An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. NeuroReport 7, 1465-1468.
54. LODDICK, S. A. & ROTHWELL, N. J. (1996). Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. Journal of Cerebral Blood Flow and Metabolism 16, 932-940.
55. LODDICK, S. A., TURNBULL, A. V. & ROTHWELL, N. J. (1998). Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischaemia in the rat. Journal of Cerebral Blood Flow and Metabolism 18, 176-179.
56. LODDICK, S. A., WONG, M.-L., BONGIORNO, P. B., GOLD, P. W., LICINIO, J. & ROTHWELL, N. J. (1997). Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochemical and Biophysical Research Communications 234, 211-215.
57. LOVENBERG, T. W., CROWE, P. D., LIU, C., CHALMERS, D. T., LIU, X. J., LIAW, C., CLEVENGER, W., OLTERSDORF, T., DE SOUZA, E. B. & MAKI, R. A. (1996). Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL-1R-rp2). Journal of Neuroimmunology 70, 113-122.
58. LUHESHI, G., HOPKINS, S. J., LEFEUVRE, R. A., DASCOMBE, M. J., GHIARA, P. & ROTHWELL, N. J. (1993). Importance of brain IL-1 type II receptors in fever and thermogenesis in the rat. American Journal of Physiology 265, 585-591.
59. LYONS, M. K., ANDERSON, R. E. & MEYER, F. B. (1991). Corticotrophin-releasing factor antagonist reduces ischaemic hippocampal neuronal injury. Brain Research 545, 339-342.
60. MARTIN, D., CHINOOKOSWONG, N. & MILLER, G. (1995). The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischaemia. Experimental Neurology 130, 362-367.
61. MARTIN, M. U. & FALK, W. (1997). The interleukin-1 receptor complex and interleukin-1 signal transduction. European Cytokine Network 8, 5-17.
62. MARTIN, D. & NEAR, S. L. (1995). Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. Journal of Neuroimmunology 61, 241-245.
63. MARTIN, D., RELTON, J. K., MULLER, G., BENDELE, A., FISCHER, N. & RUSSELL, D. (1996). Cytokines as therapeutic agents in neurological disorders. In Cytokines in the Nervous System, ed. ROTHWELL, N. J., pp. 162-178. Chapman & Hall, Boston.
64. MINAMI, M., KURAISHI, K., YABUUCHI, K., YAMAZAKI, K. & SATOH, M. (1992). Induction of interleukin-1β mRNA in rat brain transient forebrain ischaemia. Journal of Neurochemistry 58, 390-392.
65. MIURA, M., ZHU, H., ROTELLO, R., HARTWIEG, E. A. & YUAN, J. (1993). Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660.
66. MOSER, R., SCHLEIFFENBAUM, B., GROSCURTH, P. & FEHR, J. (1989). Interleukin-1 and tumour necrosis factor stimulate vascular endothelial cells to promote transendothelial neutrophil passage. Journal of Clinical Investigation 83, 444-451.
67. NICHOLSON, D. W. & THORNBERRY, N. (1997). Caspases: killer proteases. Trends in Biochemical Sciences 22, 299-306.
68. OHMORI, Y., SMITH, M. F. & HAMILTON, T. A. (1996). IL-4 induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. Journal of Immunology 57, 2058-2065.
69. OKAMURA, H., TSUTSUI, H., KOMATSU, T., YUTSUDO, M., HAKURA, A., TANIMOTO, T., TORIGOE, K., OKURA, T., NUKADA, Y. L., HATTORI, K., AKITA, K., NAMBA, M., TANABE, F., KONISHI, K., FUKUDA, S. & KURIMOTO, M. (1995). Cloning of a new cytokine that induces IFN-gamma production by T-cells. Nature 378, 88-91.
70. O'NEILL, L. A. J. (1996). Pharmacological targets in the immune response. Interleukin-1 receptors and signal transduction. Biochemical Society Transactions 24, 207-211.
71. PANEGYRES, P. K. & HUGHES, J. (1998). The neuroproteetive effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene. Journal of the Neurological Sciences 154, 123-132.
72. PARNET, P., GARKA, K. E., BONNERT, T. P., DOWER, S. K. & SIMS, J. E. (1996). IL-1Rrp is a novel receptor like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. Journal of Biological Chemistry 271, 3967-3970.
73. PEARSON, V., ROTHWELL, N. J. & TOULMOND, S. (1998). Excitotoxic brain damage in the rat induces IL-1 protein in microglia and astrocytes: correlation with the progression of cell death. Glia (in the Press).
74. PLATA-SALAMAN, C. R. & FFRENCH-MULLEN, J. M. H. (1991). Interleukin-1β depresses calcium currents in CA1 hippocampal, neurones at pathophysiological concentrations. Brain Research Bulletin 29, 221-225.
75. QUAGLIARELLO, V. J., WISPELWEY, B., LONG, W. J. JR & SCHELD, W. M. (1991). Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. Journal of Clinical Investigation 87, 1360-1366.
76. RANO, T. A., TIMKEY, T., PETERSON, E. P., ROTONDA, J., NICHOLSON, D. W., BECKER, J. W., CHAPMAN, K. T. & THORNBERRY, N. A. (1997). A combinatorial approach for determining protease specificities; application to interleukin-1β converting enzyme (ICE). Chemistry and Biology 4, 149-155.
77. REAGAN, L. P. & MCEWEN, B. S. (1997). Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. Journal of Chemical Neuroanatomy 13, 149-167.
78. RELTON, J. K., MARTIN, D., THOMPSON, R. C. & RUSSELL, D. A. (1996). Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Experimental Neurology 138, 206-213.
79. RELTON, J. K. & ROTHWELL, N. J. (1992). Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Research Bulletin 29, 243-246.
80. RELTON, J. K., STRIJBOS, P. J. L. M., O'SHAUGHNESSY, C. T., CAREY, F., FORDER, R. A., TILDERS, F. J. H. & ROTHWELL, N. J. (1991). Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. Journal of Experimental Medicine 174, 305-310.
81. RIDENOUR, T. R., WARNER, D. S., TODD, M. M. & MCALLISTER, A. C. (1992). Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats. Stroke 23, 733-738.
82. ROE, S. Y., MCGOWAN, E. M. & ROTHWELL, N. J. (1998). Evidence for the involvement of corticotrophin releasing hormone (CRH) in the pathogenesis of traumatic brain injury. European Journal of Neuroscience 10, 553-559.
83. ROTHWELL, N. J. (1997). Neuroimmune interactions: the role of cytokines. British Journal of Pharmacology 121, 841-847.
84. ROTHWELL, N. J., ALLAN, S. & TOULMOND, S. (1997). Cytokines and the brain: the role of interleukin-1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. Journal of Clinical Investigation 100, 2648-2652.
85. ROTHWELL, N. J., BUSBRIDGE, N. J., LEFEUVRE, R. A., HARDWICK, A. J., GAULDIE, J. & HOPKINS, S. J. (1991). Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Canadian Journal of Physiology and Pharmacology 69, 1465-1469.
86. ROTHWELL, N. J. & FLOWER, R. (1992). Lipocortin-1 exhibits novel actions providing clinical opportunities. Trends in Pharmacological Sciences 13, 45-46.
87. ROTHWELL, N. J. & HOPKINS, S. J. (1995). Cytokines and the nervous system. II: Actions and mechanisms of action. Trends in Neurosciences 18, 130-136.
88. ROTHVVELL, N. J., LODDICK, S. A. & STROEMER, P. (1996a). Interleukins and cerebral ischaemia. In Neuroprotective Agents and Cerebral Ischaemia, ed. GREEN, A. R. & CROSS, A. J., pp. 281-298. Academic Press, New York.
89. ROTHWELL, N. J. & LUHESHI, G. N. (1994). Pharmacology of interleukin-1 actions in the brain. Advances in Pharmacology 25, 1-20.
90. ROTHWELL, N. J., LUHESHI, G. & TOULMOND, S. (1996b). Cytokines and their receptors in the central nervous system: Physiology, pharmacology and pathology. Pharmacological Therapeutics 69, 85-95.
91. ROTHWELL, N. J. & STOCK, M. J. (1978). Mechanisms of weight gain and loss in reversible obesity in the rat. Journal of Physiology 276, 60-61P.
92. ROTHWELL, N. J. & STOCK, M. J. (1984). Brown adipose tissue. In Recent Advances in Physiology, vol. 10, ed. BAKER, P. F., pp. 349-384. Churchill Livingstone, Edinburgh.
93. ROTHWELL, N. J. & STOCK, N. J. (1986). Brown adipose tissue and diet-induced thermogenesis. In Brown Adipose Tissue, ed. TRAYHURN, P. & NICHOLLS, D. G., pp. 269-298. Edward Arnold, London.
94. ROTHWELL, N. J., STROEMER, P., LAWRENCE, C. & DAVIES, C. (1996c). Actions of IL-1 in neurodegeneration. In Pharmacology of Cerebral Ischaemia, ed. KRIEGELTEIN, J., pp. 125-129. Medpharm, Stuttgart.
95. ROYSTON, M. C., ROTHWELL, N. J. & ROBERTS, G. W. (1992). Alzheimer's disease: pathology to potential treatments. Trends in Pharmacological Sciences 13, 131-133.
96. SAPOLSKY, R. M. & PULSINELLI, W. A. (1985). Glucocorticoids potentiate ischaemic injury to neurons: therapeutic implications. Science 229, 1397-1399.
97. SCHIELKE, G. P., YANG, G. Y., SHIVERS, B. D. & BETZ, A. L. (1998). Reduced ischaemic brain injury in interleukin-1 beta converting enzyme-deficient mice. Journal of Cerebral Blood Flow and Metabolism 18, 180-185.
98. SHENG, J. G., ITO, K., SKINNER, R. D., MRAK, R. E., ROVNAGHI, C. R., VAN ELDIK, L. & GRIFFIN, W. S. T. (1996). In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiology of Ageing 7, 761-766.
99. SHRIKANT, P., CHUNG, I. Y., BALLESTAS, M. E. & BENVENISTE, E. N. (1994). Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes. Journal of Neuroimmunology 51, 209-220.
100. SIMMONS, M. L. & MURPHY, S. (1993). Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. European Journal of Neuroscience 5, 825-832.
101. SIMS, J., GAYLE, M. A., SLACK, J. L., ALDERSON, M. R., BIRD, T. A., GIRI, J. G., COLOTTA, F., RE, F., MANTOVANI, A., SHANEBECK, K., GRABSTEIN, K. H. & DOWER, S. K. (1993). Interleukin-1 signalling occurs exclusively via the type I receptor. Proceedings of the National Academy of Sciences of the USA 90, 6155-6159.
102. SOLITO, E., DE COUPADE, C., PARENTE, L., FLOWER, R. J. & RUSSO-MARIE, F. (1998). IL-6 stimulates annexin-1 expression and translocation, and suggests a new biological role as class II acute phase protein. Cytokine (in the Press).
103. SPRANGER, M., LINDHOLM, D., BANDTLOW, C., HEUMANN, R., GHAHN, H., NÄHER-NOÉ, M. & THOENEN, H. (1990). Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. European Journal of Neuroscience 2, 69-76.
104. STRIJBOS, P. J. L. M., RELTON, J. K. & ROTHWELL, N. J. (1994). Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebal ischaemia or activation of NMDA receptors in the rat brain. Brain Research 656, 405-408.
105. STRIJBOS, P. J. L. M. & ROTHWELL, N. J. (1995). Interleukin-1β attenuates excitatory amino acid induced neurodegeneration in vitro: involvement of nerve growth factor. Journal of Neuroscience 15, 3468-3474.
106. STROEMER, R. P. & ROTHWELL, N. J. (1997). Cortical protection by localised striatal injection of IL-1ra following cerebral ischaemia in the rat. Journal of Cerebral Blood Flow and Metabolism 17, 597-604.
107. STROEMER, R. P. & ROTHWELL, N. J. (1998). Exacerbation of ischaemic brain damage by localised striatal injection of IL-1β in the rat. Journal of Cerebral Blood Flow and Metabolism (in the Press).
108. SULLIVAN, G. W., CARPER, H. T., SULLIVAN, J. A., MURATA, T. & MANDELL, G. L. (1989). Both recombinant interleukin-1 (beta) and purified human monocyte interleukin-1 prime human neutrophils for increased oxidative activity and promote neutrophil spreading. Journal of Leukocyte Biology 45, 389-395.
109. TAUPIN, V., TOULMOND, S., SERRANO, A., BENAVIDES, J. & ZAVALA, F. (1993). Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre-and post-traumatic treatment with R05 4864 a peripheral-type (p site) benzodiazepine ligand. Journal of Neuroimmunology 42, 177-185.
110. THORNBERRY, N. A., BULL, H. G., CALAYCAY, J. R., CHAPMAN, K. T., HOWARD, A. D., KOSTURA, M. J., MILLER, D. K., MOLINEAUX, S. M., WEIDNER, J. R., AUNINS, J., ELLISTAN, K. O., AYALA, J. M., CASANO, F. J., CHIN, J., DING, G. J.-F., EGGER, L. A., GAFFNEY, E. P., LIMJUCO, G., PALYHA, O. C., RAJU, S. M., ROLANDO, A. M., SALLEY, J. P., YANIN, T.-T., LEE, T. D., SHIVELY, J. E., MACCROSS, M., MUMFORD, R. A., SCHMIDT, J. A. & TOCCI, M. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774.
111. TISDALE, M. J. (1997). Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition 13, 1-7.
112. TORIGOE, K., USHIO, S., OKURA, T., KOBAYASHI, S., TANIAI, M., KUNIKATA, T., MURAKAMI, T., SANOU, O., KOJIMA, H., FUJII, M., OHTA, T., IKEDA, M., IKEGAMI, H. & KURIMOTO, M. (1997). Purification and characterisation of the human interleukin-18 receptor. Journal of Biological Chemistry 272, 25737-25742.
113. TOULMOND, S. & ROTHWELL, N. J. (1995a). Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Research 671, 261-266.
114. TOULMOND, S. & ROTHWELL, N. J. (1956). Time course of IL-1 receptor antagonist (IL-1ra) expression after brain trauma in the rat. Society for Neuroscience Abstracts 21, 200.2.
115. TOULMOND, S., VIGE, X., FAGE, D. & BENAVIDES, J. (1992). Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neuroscience Letters 144, 49-52.
116. TROY, C. C., STEFANIS, L., PROCHIANTZ, A., GREENE, L. A. & SHELANSKI, M. L. (1996). The contrasting roles of ICE family proteases and interleukin-1β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase downregulation. Proceedings of the National Academy of Sciences of the USA 93, 5635-5640.
117. VANNIER, E., MILLER, L. C. & DINARELLO, C. A. (1992). Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proceedings of the National Academy of Sciences of the USA 89, 4076-4080.
118. WANG, X., BARONE, F., AIYAR, N. V. & FEUERSTEIN, G. Z. (1997). Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28, 155-162.
119. WONG, M. L., LODDICK, S. A., BONGIORNO, P. B., GOLD, P. W., LICINIO, J. & ROTHWELL, N. J. (1995). Focal cerebral ischaemia induces CRH mRNA in rat cerebral cortex and amygdala. NeuroReport 6, 1785-1788.
120. YABUUCHI, K., MINAMI, M., KATSUMATA, S., YAMASAKI, A. & SATOH, M. A. (1994). An in situ hybridisation study of interleukin-1 beta induced by transient forebrain ischaemia in the rat brain. Molecular Brain Research 26, 135-142.
121. YAMASAKI, Y., MATSUURA, N., SHOZUHARA, H., ONODERA, H., ITOYAMA, Y. & KOGURE, K. (1995). Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26, 676-681.
122. YAMASAKI, Y., SHOZUHARA, H., ONODERA, H. & KOGURE, K. (1994). Blocking of interleukin-1 activity is a beneficial approach to ischemia brain edema formation. Acta Neurochirugica Supplement 60, 300-302.
123. YAMASAKI, Y., SUZUKI, T., YAMAYA, H., MATSUURA, N., ONODERA, H. & KOGURE, K. (1992). Possible involvement of interleukin-1 in ischemic brain edema formation. Neuroscience Letters 142, 45-47.
124. YUAN, J., SHAHAM, S., LEDOUX, S., ELLIS, H. M. & HORVITZ, H. R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641-652.